Brief: Valbiotis Announces Positive Preclinical Results For TOTUM-070 In Hypercholesterolemia

Valbiotis SA

15/11/2021 07:42

Nov 15 (Reuters) - Valbiotis SA  ALVAL.PA :
    * ANNOUNCES POSITIVE PRECLINICAL RESULTS FOR TOTUM-070 IN
HYPERCHOLESTEROLEMIA, SELECTED AND PRESENTED AT THE AMERICAN
HEART ASSOCIATION (AHA) ANNUAL MEETING
    * FIRST DATA IN FAVOUR OF A MULTI-TARGET MODE OF ACTION OF
TOTUM-070, WITH REVEALED EFFECTS ON THE GUT AND LIVER, INVOLVING
LIPID METABOLISM AND INFLAMMATION

Source text for Eikon:  ID:nBw6rcj9ma 
Further company coverage:  ALVAL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))